A Diagnostic Leader in personalized onco-medicine

Providing High-Quality Gene Expression Prognostic & Predictive Services for the Personalized Medicine
arena to Enable Better Management of Cancer Patients

Contact Info

Phone:
(609) 619-2776

Email: emmanuel@oncopathgenomics.com

Address:

7 Deer Park Drive,
Suite M-2
Princeton Corporate Plaza
Monmouth  Junction, NJ 08852
Cell: (732) 485-5428

Next-Gen Sequencing

OncoPath Genomics provides high-quality genomic prognostic and predictive Services for the Personalized Medicine arena to Enable Better Management of Cancer Patients.

Serving researchers at academic, pharmaceutical, clinical, biotechnology, and government institutions, OncoPath Genomics specializes in cancer translation research applications.
 
OncoPath’s RNA and DNA Illumina technology platform -NextGen  DNA/RNA sequencing - together with our state-of-the-art NSG facilities, provides best in class science that can be applied for a wide variety of applications including measuring endpoints of key importance in gene regulation and the resulting biological effects.

Next-Gen DNA Sequencing

RNA Sequencing Services

Custom NGS Services

Other Gene Expression Service

Other SNP Services

Other Molecular Biological  Services

Bioinformatics Support

Clinical Research Training